These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Kaswala DH; Lai M; Afdhal NH Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224 [TBL] [Abstract][Full Text] [Related]
7. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis. Henry ZH; Argo CK Gastroenterol Clin North Am; 2020 Mar; 49(1):45-62. PubMed ID: 32033764 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and diagnosis of NAFLD/NASH. Hashimoto E; Taniai M; Tokushige K J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707 [TBL] [Abstract][Full Text] [Related]
10. Can NASH be diagnosed, graded, and staged noninvasively? Grandison GA; Angulo P Clin Liver Dis; 2012 Aug; 16(3):567-85. PubMed ID: 22824481 [TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Tsai E; Lee TP Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062 [TBL] [Abstract][Full Text] [Related]
13. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH. Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Wieckowska A; McCullough AJ; Feldstein AE Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Castera L; Friedrich-Rust M; Loomba R Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725 [TBL] [Abstract][Full Text] [Related]
16. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316 [TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Masuoka HC; Chalasani N Ann N Y Acad Sci; 2013 Apr; 1281(1):106-22. PubMed ID: 23363012 [TBL] [Abstract][Full Text] [Related]